DAPredict: a database for drug action phenotype prediction

Qingkang Meng,Yiyang Cai,Kun Zhou,Fei Xu,Diwei Huo,Hongbo Xie,Meini Yu,Denan Zhang,Xiujie Chen

DOI: https://doi.org/10.1093/database/baad095

2024-01-01

Database

Abstract:Abstract The phenotypes of drug action, including therapeutic actions and adverse drug reactions (ADRs), are important indicators for evaluating the druggability of new drugs and repositioning the approved drugs. Here, we provide a user-friendly database, DAPredict (http://bio-bigdata.hrbmu.edu.cn/DAPredict), in which our novel original drug action phenotypes prediction algorithm (Yang,J., Zhang,D., Liu,L. et al. (2021) Computational drug repositioning based on the relationships between substructure-indication. Brief. Bioinformatics, 22, bbaa348) was embedded. Our algorithm integrates characteristics of chemical genomics and pharmacogenomics, breaking through the limitations that traditional drug development process based on phenotype cannot analyze the mechanism of drug action. Predicting phenotypes of drug action based on the local active structures of drugs and proteins can achieve more innovative drug discovery across drug categories and simultaneously evaluate drug efficacy and safety, rather than traditional one-by-one evaluation. DAPredict contains 305 981 predicted relationships between 1748 approved drugs and 454 ADRs, 83 117 predicted relationships between 1478 approved drugs and 178 Anatomical Therapeutic Chemicals (ATC). More importantly, DAPredict provides an online prediction tool, which researchers can use to predict the action phenotypic spectrum of more than 110 000 000 compounds (including about 168 000 natural products) and corresponding proteins to analyze their potential effect mechanisms. DAPredict can also help researchers obtain the phenotype-corresponding active structures for structural optimization of new drug candidates, making it easier to evaluate the druggability of new drug candidates and develop more innovative drugs across drug categories. Database URL: http://bio-bigdata.hrbmu.edu.cn/DAPredict/

mathematical & computational biology

What problem does this paper attempt to address?

The paper introduces a database called DAPredict, which aims to predict drug action phenotypes, including therapeutic effects and adverse reactions. The current drug development process is based on disease models, which is time-consuming, expensive, and has a low success rate, especially in comprehensively analyzing drug action mechanisms. DAPredict overcomes the limitations of traditional methods by integrating chemical genomics and pharmacogenomics features, using the local active structures of drugs and proteins to predict innovative discoveries of cross-category drugs, and simultaneously evaluating drug efficacy and safety. DAPredict contains 305,981 predicted relationships between 1748 approved drugs and 454 adverse reactions (ADRs), as well as 1478 approved drugs and 178 anatomical therapeutic chemical (ATC) classifications. In addition, it provides an online prediction tool that can predict the action phenotypic spectrum of over 110 million compounds (including approximately 168,000 natural products) and their corresponding proteins to analyze their potential action mechanisms. This database also helps researchers obtain phenotype-relevant active structures of new drug candidates, facilitating the optimization of their structures and the evaluation of drug-like properties. The algorithm of DAPredict is based on the local active structures of drugs and proteins, addressing the "activity cliff" phenomenon that exists in traditional global structure similarity prediction methods, where structurally similar drugs may have different functional effects. Through this approach, DAPredict can provide more accurate drug action predictions and accelerate the drug development process.

DAPredict: a database for drug action phenotype prediction

Predicting Protein-Ligand Interactions Based on Bow-Pharmacological Space and Bayesian Additive Regression Trees

DDIT: An Online Predictor for Multiple Clinical Phenotypic Drug-Disease Associations

KG-Predict: A knowledge graph computational framework for drug repurposing

DBPP-Predictor: a novel strategy for prediction of chemical drug-likeness based on property profiles

Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space.

DeepACTION: A deep learning-based method for predicting novel drug-target interactions

Adverse drug events: database construction and in silico prediction.

Drug target, class level, and PathFX pathway information share utility for machine learning prediction of common drug-induced side effects

DRAR-CPI: a Server for Identifying Drug Repositioning Potential and Adverse Drug Reactions Via the Chemical-Protein Interactome.

BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs

Predicting compound activity from phenotypic profiles and chemical structures

Drug Repositioning by Prediction of Drug's Anatomical Therapeutic Chemical Code Via Network-Based Inference Approaches.

DrugRepoBank: a comprehensive database and discovery platform for accelerating drug repositioning

Drug–drug interaction prediction: databases, web servers and computational models

Sdtnbi: an Integrated Network and Chemoinformatics Tool for Systematic Prediction of Drug-Target Interactions and Drug Repositioning

Author Correction: Prediction of New Drug Indications Based on Clinical Data and Network Modularity

In Silico Prediction Of Adverse Drug Reactions And Toxicities Based On Structural, Biological And Clinical Data

DPDR-CPI, a Server That Predicts Drug Positioning and Drug Repositioning Via Chemical-Protein Interactome

DRUG-TARGET INTERACTION PREDICTION BY INTEGRATING CHEMICAL, GENOMIC, FUNCTIONAL AND PHARMACOLOGICAL DATA

Molecular Docking for Prediction and Interpretation of Adverse Drug Reactions.